This site is intended for health professionals only

At the heart of general practice since 1960

pul jul aug2020 cover 80x101px
Read the latest issue online

Independents' Day

One in four adults prescribed addictive medicines, says PHE review

Over 11 million adults in England were prescribed addictive drugs between 2017 and 2018, according to a major new review by public health officials who said they recognised the 'great pressure' GPs are under to provide access to medication.

The Public Health England review, which looked at data for five commonly prescribed medicines - antidepressants, opioids, gabapentinoids, benzodiazepines and z-drugs - found that 26% of adults in England received a prescription for one or more of these drugs in the 12 months prior to March 2018.

GP leaders have said it is 'encouraging' the review shows a decline in opioid prescriptions for chronic pain, and also welcomed the report's call for more support services to help GPs and patients manage withdrawal in the community.

The PHE review said it was 'difficult to determine' the prevalence of dependence on, or withdrawal from, the medicines covered in the review.

However, it concluded the data on the duration of prescribing suggests that dependence and withdrawal are 'likely to be significant issues, particularly when seen together with the significant concerns raised by some patients, campaigners and others'.

The data showed that in March 2018, among all those people in receipt of a prescription, around half of patients for each medicine type were estimated to have been receiving a prescription continuously for at least 12 months.

While long-term prescribing may be clinically appropriate for some patients, the review stressed the importance of regular reviews to avoid people developing dependence or experiencing withdrawal.

'Patients may come to medical appointments with a clear expectation that medicines will meet their needs, and some will assertively make a case to receive a prescription. Increased awareness among the public and clinicians of treatments that are alternative, or supplementary, to medicines, and of the risks and benefits of medicines, is vital,' said the report.

The data analysed for the review also showed prescribing rates and the length of prescriptions were higher in more deprived areas of the country. 

PHE admitted that GPs in these regions were under ‘great pressure’ to prescribe drugs, and said alternative treatments needed to be considered.

Rosanna O’Connor, director of alcohol, drugs, tobacco and justice at PHE, said: ‘We know that GPs in some of the more deprived areas are under great pressure but, as this review highlights, more needs to be done to educate and support patients, as well as looking closely at prescribing practice and what alternative treatments are available locally.

‘While the scale and nature of opioid prescribing does not reflect the so-called crisis in North America, the NHS needs to take action now to protect patients.’

Commenting on today's findings, Dr Andrew Green, who represented the BMA during PHE's drug review, said: 'Doctors in the UK are of course concerned at the number of patients being prescribed these medicines, and the length of time they are taking them for.

'While there isn’t a single cause for high prescription rates, social deprivation, an increased prevalence of mental health problems and poor access to mental health care, a rise in the demand for GP services and a growing, aging population, are likely to be significant contributing factors.'

He added: 'It is positive that this report recognises that to reduce prescription levels, we need significant investment in support services; this will enable patients and GPs to manage dependencies together in the community. GPs will often be the sole clinicians who are managing a patient’s withdrawal, and there is a real need for better clinical guidance in this respect. We are glad that NICE is in the process of developing this.'

Professor Helen Stokes-Lampard, chair of the RCGP, said: ‘This report analyses prescribing data for medications that when prescribed appropriately can be effective and beneficial for many patients – and it shows that the vast majority of prescriptions issued are short term, and that we are seeing a decline in opioid prescriptions for chronic pain, both of which are encouraging trends.

‘What it also indicates is the severe lack of alternatives to drug therapies for many conditions – and where effective alternatives are known and exist, inadequate and unequal access to them across the country.'

GPs previously urged the Government to increase funding for pain services, as often a lack of specialist services often leaves them with no option but to prescribe addictive medication.

The review was announced in January in response to NHS Digital data which showed an increase in the number of patients prescribed an addictive medicine in the previous five years.

Key recommendations from PHE's review of addictive medications 

  • Doctors and commissioners should be given better access to data to improve prescribing behaviour;
  • Updates to clinical guidance for medicines which can cause problems with dependence and withdrawal – and the safe management of this;
  • Better information for patients about benefits and risks of medicines
  • More discussions between doctors and patients, and more alternatives offered including social prescribing;
  • A national helpline for patients and local support;
  • More research around dependence and withdrawal.

Readers' comments (30)

  • Inability of so many docs to say no is surprising, but perhaps the lawyers will change that.

    Unsuitable or offensive? Report this comment

  • Holy smoke batman.
    I’m wondering exactly how much actual training you have had in psychiatry? I know that you can be a GP with precisely nil following medical school. Here in lies the problem. To say that antidepressants are no better than placebo proves that you don’t know the evidence and are treating the wrong population or using them in the wrong way- something I see all the time. Misinformation is appalling for patient where antidepressants are re absolutely life saving.

    Unsuitable or offensive? Report this comment

  • It is beyond doubt that prescription of addictive drugs including opiates is driven by multiple factors well outside the control of general practice.
    However it is true that their is a difference in ability of individual GPs even within the same local systems to decline to prescribe.
    It is akin to antibiotic prescribing rates.
    Rather than just ranking and blaming we need to learn the consulting skills that the low prescribers have to lower overall rates.
    There are many good MSK courses that can help with this.

    Unsuitable or offensive? Report this comment

  • I remember in the 1980s as a junior doc we were being berated for NOT TREATING PAIN PROPERLY. The analgesic ladder was published in 1986 and eventually anyone at A&E with a sprained ankle or even undiagnosed pain was sent away with some co-codamol 30/500 or similar. And the rest is history.

    Unsuitable or offensive? Report this comment

  • But don't worry, the PCN-funded pharmacist will solve all these problems....

    Unsuitable or offensive? Report this comment

  • "Patient education" Where have I heard that before?? Ah yes, antibiotics. Another success leading to increased patient complaints and more paperwork. "Just give me the painkillers and educate the next patient"

    Unsuitable or offensive? Report this comment

  • Here is an idea

    How about PHE/NHSE/CCG/PCN or whichever else organisation with time on its hands knock up some posters for our surgeries..

    "this is a non-prescribing GP practice
    We are not allowed to prescribe anything, for the risk of harm
    We are however happy to do the jobs of others and talk to you about fixing you boiler, gambling problems, safeguarding issues or refer you to Prevent if you are a nutty terrorist, or listen to you moan about your terrible life.
    Hugs and kisses, your local friendly GP"

    Unsuitable or offensive? Report this comment

  • "Psychiatric drugs and some general medications have effects that are not always the ones that are intended".

    "Reactions to different drugs and drug-drug combinations are governed by individual metabolising rates".

    "It is established (that) genetic polymorphisms in the CYP 450 and serotoninergic metabolising system cause higher drug levels which are associated with neuropsychiatric adverse drug reactions (ADRs) such as akathisia".

    "If not recognised, akathisia, which often precedes violence, suicidality, homicide, mania and psychosis, may be mistaken for new or emergent mental illness and treated with further ineffective, counter-productive psychiatric drugs".

    Reference: -

    Treatment Emergent Violence To Self And Others; A literature Review of Neuropsychiatric Adverse Reactions For Antidepressant And Neuroleptic Psychiatric Drugs And General Medications.

    Clarke C. Evans J. Brogan K. 2019.

    US National Library of Medicine. N.I.H. Adv Mind Body Med. 2019. Winter, 33(1): 4-21.

    (It is recognised that reports of akathisia as a precursor to harm against self and/or others are subject to widely different opinion and interpretation).

    Unsuitable or offensive? Report this comment

  • And? Who made available these medications? Who requested, no, demanded them? Which Governance organism advocated the use of Gabapentinoids??? And don't get me started on trying to get patients to change their life style choices... Expectations are nearly impossible to fulfil, the culture of "I want it all and I want it now" has done no favours to anyone, even less people that needs help!

    Unsuitable or offensive? Report this comment

  • Oh dear, it seems our foolish and uncaring actions have finally been revealed.
    I too remember the "Defeat Depression Campaign" and the other big cultural push to treat pain effectively.
    No data I have seen this week on how many patients are on analgaesia because:
    1. they are currently waiting for a long time for definitive treatment (eg joint replacement)
    2.they have been to clinic, "nothing more I can do for you, go back to your GP"
    3. anecdotally, outcome from Pain Clinic is not great "nice people but I still have a lot of pain, Dr" Some great individual results but not the norm.
    4. "If I take this painkiller I can sleep / move/ go to work and pay taxes/ look after my frail relative". (delete as applicable)
    Sorry to tell you that they help a lot of people to function.
    As soon as there is a well thought-out , accessible, effective pathway for patients who are taking opiates and antidepressants "wrongly", I'll gladly refer. I'm waiting, and waiting...
    Can't have opiates, can't have antidepressants, mustn't take NSAIDs, can't have "gabapentinoids" : we are entitled to some defence and clinical leadership here.
    I have just come back form visiting family in USA.. I was horrified to see complex and poweful meds being advertised to the public on TV: " if you have joint pain and your golf swing is worsening, go ask your Physician for Etanercept" WTF. We have a lot to be thankful and thanked for!

    Unsuitable or offensive? Report this comment

View results 10 results per page20 results per page50 results per page

Have your say